Clinical Trials: Design, Conduct, and AnalysisOxford University Press, 1986 - 469 pages The definitive reference work on clinical trials, this book presents a wealth of detailed, practical information on the design, conduct, and analysis of both single center and multicenter trials. No other book on clinical trials offers as much detail as Meinert does on such issues as sample size calculation, stratification and randomization, data systems design, consent form development, publication policies, preparation of funding requests, and reporting procedures. |
From inside the book
Results 1-5 of 86
Page xi
... funding 3.4 Approaches to ensure orderly transition of activities 3.4.1 Phased initiation of data intake 3.4.2 An ... funds 20 20 5.3 Central laboratories 20 5.4 Reading centers 22 20 5.5 Project offices 5.6 Other resource centers ...
... funding 3.4 Approaches to ensure orderly transition of activities 3.4.1 Phased initiation of data intake 3.4.2 An ... funds 20 20 5.3 Central laboratories 20 5.4 Reading centers 22 20 5.5 Project offices 5.6 Other resource centers ...
Page xii
... funding comparable study groups 6.4.3 Cost reviews 6.4.4 Periodic priority assessments 8.5 Principles of masking and bias control 6.4.5 Review and funding for ancillary studies 6.4.6 Justification of data items 6.4.7 Use of low ...
... funding comparable study groups 6.4.3 Cost reviews 6.4.4 Periodic priority assessments 8.5 Principles of masking and bias control 6.4.5 Review and funding for ancillary studies 6.4.6 Justification of data items 6.4.7 Use of low ...
Page xvi
... funding proposal Chapter 20. Interim data analyses for treatment monitoring 21.7 Negotiations and award 21.8 Grant and contract 20.1 Introduction administration 20.2 Procedural issues 21.9 Special funding issues 20.3 Treatment ...
... funding proposal Chapter 20. Interim data analyses for treatment monitoring 21.7 Negotiations and award 21.8 Grant and contract 20.1 Introduction administration 20.2 Procedural issues 21.9 Special funding issues 20.3 Treatment ...
Page xxi
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page xxv
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Contents
A stateof | 1 |
223 | 12 |
The activities of | 18 |
Cost and related issues | 40 |
masked allocation | 90 |
Use of items from other | 119 |
Patient recruitment | 149 |
Patient followup | 185 |
randomization | 219 |
Essential management | 232 |
Preparation of | 264 |
Appendix H Budget summary | 279 |
Other editions - View all
Common terms and phrases
Abstract summaries advisory-review allocation ratio Aspirin assess baseline Chapter clinical trial close-out consent control treatment Coronary Drug Project cost data center data collection data coordinating center data dredging data entry data forms database disease Drug Project Research Fisher's exact test follow-up visit funding Gallstone Group Diabetes Program Hypertension Institute investigators laboratory masked ment methods monitoring committee multicenter trials myocardial infarction NCGS needed niacin number of patients outcome measure p-value paper patient recruitment patients enrolled phenformin physician placebo procedures Program Research Group Project Research Group protocol publication Question randomization records responsible safety monitoring sample sample size schedule Section specified sponsor study treatments subgroups TEMC test treatment tients tion tolbutamide treat treatment allocation treatment assignment treatment effects monitoring treatment group treatment monitoring trial involving trials sketched UGDP University Group Diabetes variable Yes Yes Yes